Results 191 to 200 of about 37,338 (299)

Ovarian intelligence: AI applications leveraging AMH and inhibin B. [PDF]

Front Endocrinol (Lausanne)
Xu H, Bischoff F, Wang Q, Li R.
europepmc   +1 more source

Dissecting the genetic basis of drought escape across multiple traits in colonizing Arabidopsis thaliana lineages

New Phytologist, Volume 251, Issue 1, Page 537-554, July 2026.
Cape Verde Islandspopulations experience seasonal drought and high humidity during the growing season, driving drought escape strategies relative to their Moroccan outgroup. Summary Drought response in plants is complex, involving integration across a range of physiological processes.
Ahmed F. Elfarargi, Elodie Gilbault, Nina Döring, Herculano Dinis, Andreas P. M. Weber, Olivier Loudet, Angela M. Hancock   +6 more
wiley   +1 more source

Retrospective analysis of the association between anti-Müllerian hormone levels and metabolism and reproductive outcome across different PCOS phenotypes. [PDF]

Am J Transl Res
Lu L, Wang Y, Yan J, Zhao M.
europepmc   +1 more source

Mechanism and Intervention of the NPY1R/CREB Signaling Axis in Regulating Inflammatory Response in Aged Ovarian Granulosa Cells and Ovarian Senescence

The FASEB Journal, Volume 40, Issue 12, 30 June 2026.
Aging‐associated upregulation of NPY1R drives p‐CREB activation, triggering inflammation, mitochondrial dysfunction, and extracellular matrix imbalance to promote ovarian senescence. Pharmacological inhibition of NPY1R with BIBO 3304 restores ovarian homeostasis, highlighting a therapeutic strategy for reproductive aging. ABSTRACT Ovarian senescence is
Junnan Fang, Chaoying Wang, Shuaishuai Guo, Yiping Zhang, Yang Zhang, Huihui Wang, Yue Kong, Haixia Jin, Lin Qi, Yan Liu, Zhaoting Wu, Fuli Zhang, Shuang Wen, Xiaopeng Wang, Guang Yang, Guidong Yao   +15 more
wiley   +1 more source

A New Diagnostic Strategy for Polycystic Ovary Syndrome Combining Japanese and International Diagnostic Criteria Using Anti-Müllerian Hormone. [PDF]

J Obstet Gynaecol Res
Noguchi H, Iwasa T, Iwase A, Kanasaki H, Kimura F, Kugu K, Saito K, Baba T, Hara T, Matsuzaki T.   +9 more
europepmc   +1 more source

The Hormonal-Metabolic Puzzle of PCOS: Linking AMH Levels, Body Fat Distribution, and Insulin Resistance in Overweight and Obese Women. [PDF]

Metabolites
Gorzko A, Nawrocka-Rutkowska J, Brodowska A, Śliwak E, Starczewski A, Szydłowska I.   +5 more
europepmc   +1 more source

Predictors of early response to GnRH and gonadotropin therapy in pediatric patients with suspected dual congenital hypogonadotropic hypogonadism: a retrospective single-center study. [PDF]

Front Endocrinol (Lausanne)
Zhang Q, Wang Y, Cao B, Wang X, Yuan Z, Dou X, Gong C.   +6 more
europepmc   +1 more source

Tunable Bio‐Derived Bimetallic Cu–Zn/2‐AA Metal–Organic Framework as an Efficient Electrode Modifier for Detection of Cadmium and Dopamine

ChemElectroChem, Volume 13, Issue 11, 3 June 2026.
A bio‐derived bimetallic Cu–Zn/2‐AA metal–organic framework is developed as an efficient electrode modifier for dual electrochemical sensing. The platform delivers ultrasensitive detection of cadmium and dopamine with femtomolar to attomolar limits and enhanced selectivity. The synergistic metal centers and porous structure significantly improve charge
Fahmida Akter Sahara, Shishir Kumar Dey, Md. Arafat Ali, Md. Razu Ahmed, Md. Hridoy Ali, Zarin Tasnim Nijhum, Md. Khairul Amin, Sagar Kumar Dutta   +7 more
wiley   +1 more source

The Effect of Laparoscopic Dermoid Cystectomy on Anti-Mullerian Hormone: A Case Series. [PDF]

J Med Cases
Kumar P, Merkur H, Russell P, Wong C.
europepmc   +1 more source

Long‐Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus Erythematosus

ACR Open Rheumatology, Volume 8, Issue 6, June 2026.
Objective To evaluate the long‐term effects of anifrolumab on hematologic and serologic parameters over four years. Methods This analysis included 536 patients with moderate‐to‐severe systemic lupus erythematosus (SLE) who received intravenous anifrolumab 300 mg (n = 358) or placebo (n = 178) in the 52‐week, phase 3 TULIP‐1/2 trials (NCT02446912 and ...
Edward M. Vital, Zahir Amoura, Kenneth C. Kalunian, Ian N. Bruce, Yoshiya Tanaka, Susan Manzi, Ihor Hupka, Jacob Knagenhjelm, Hussein Al‐Mossawi, Catharina Lindholm   +9 more
wiley   +1 more source